Re-fixating Dislocated Scleral Fixing Intra-ocular Lens
A Novel Technique of Re-fixating Dislocated Scleral Fixing Intra-ocular Lens
1 other identifier
interventional
5
1 country
1
Brief Summary
To minimize multiple manipulations and to decrease the economical burden; here, we describe how to utilize the patient's own dislocated intraocular lens to re-fixate with the sclera.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 19, 2022
CompletedFirst Posted
Study publicly available on registry
March 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2023
CompletedMarch 24, 2023
March 1, 2023
1.2 years
February 19, 2022
March 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The slit-lamp examination.
To assess the intra-ocular pressure mmHg, the re-fixated intraocular lens position ( central, tilted or displaced),and leakage from the incisions, and the hemorrhage ( whether in the anterior segment or in the posterior segment).
The fourth week post-operatively.
Secondary Outcomes (1)
The visual acuity.
The fourth week post-operatively.
Study Arms (1)
The scleral pocket for the primary implanted IOL
OTHERsingle arm
Interventions
The participant's primary IOL is re-fixed without utilizing any new material.
Eligibility Criteria
You may qualify if:
- Dislocated primary scleral fixed IOL
You may not qualify if:
- Iris claw IOL
- Anterior chamber IOL
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ibinsina Modern eye and retina center
Erbil, 44001, Iraq
Study Officials
- PRINCIPAL INVESTIGATOR
Omer Abdullah, M.Sc.
Ibinsina Modern Eye and Retina Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate consultant ophthalmologist
Study Record Dates
First Submitted
February 19, 2022
First Posted
March 14, 2022
Study Start
January 1, 2022
Primary Completion
March 21, 2023
Study Completion
March 21, 2023
Last Updated
March 24, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share